Ardent Health Partners, Inc.

NYSE•ARDT

CEO: Mr. Martin J. Bonick FACHE, M.H.A.

セクター: Healthcare

業種: Medical - Care Facilities

上場日:

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

連絡先情報

340 Seven Springs Way, Suite 100, Brentwood, TN, 37027, United States

615-296-3000

www.ardenthealth.com

時価総額

$1.34B

PER (TTM)

9.8

13.4

配当利回り

52週高値

$15.48

52週安値

$7.71

52週レンジ

21%

順位41Top 44.9%

4.0

F-Score

改良版 Piotroski 分析

8年ファンダメンタル

堅調 • 4 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2018-2025

財務ダッシュボード

Q1 2026 データ

売上高

$1.60B+0.00%

直近4四半期の推移

EPS

$0.28+0.00%

直近4四半期の推移

フリーCF

-$88.31M+0.00%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Total Revenue Growth Total revenue reached $6.32B USD, marking a 6.0% increase over prior year results for 2025.

Net Income Attributable Decline Net income attributable to Ardent Health, Inc. fell to $135.8M USD, down 35.4% from $210.3M USD in 2024.

Medicaid Supplemental Payments Medicaid supplemental payments revenue reached $707.5M USD, a key driver supporting net patient revenue growth.

Adjusted Admissions Expansion Adjusted admissions grew 2.3% to 349,614 units, supported by 5.3% growth in total admissions volume.

リスク要因

Government Reimbursement Pressure Government healthcare program changes, including Medicaid funding cuts, pose material adverse effects on revenues and operating margins.

Cybersecurity Incident Aftermath Cybersecurity incident caused operational delays, incurred remediation costs, and maintains heightened risk from evolving ransomware threats.

Labor Cost Inflation Risks Labor shortages and wage inflation increase operating costs, constraining ability to offset expenses via fixed reimbursement rates.

Indebtedness Refinancing Exposure Significant indebtedness subjects operations to refinancing risks and financial restrictions imposed by governing debt covenants.

見通し

Growth Strategy Focus Strategy centers on targeted market share growth, operational excellence, and disciplined capital allocation moving forward.

Technology Integration Expansion Continue investing in advanced technologies like AI and Epic to enhance care coordination and system productivity.

JV Partnership Model Replication Expect to replicate differentiated Joint Venture model to expand footprint in mid-sized urban communities successfully.

同業比較

売上高 (TTM)

ARDT

$6.43B

+6.7%

SEM

$5.52B

+29.2%

ASTH

$3.53B

+56.7%

粗利益率 (最新四半期)

IBRX

99.5%

-12.9pp

LFST

33.7%

-0.1pp

ADUS

31.9%

+0.4pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
IBRX	$7.44B	-8.5	138.7%	173.9%
LFST	$3.30B	141.9	1.6%	9.1%
BKD	$3.21B	-15.6	40118.6%	93.5%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

-0.9%

横ばい

4四半期純利益CAGR

-18.3%

収益性の低下

キャッシュフロー安定性

75%

キャッシュフローの変動が大きい

深度リサーチ

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし